The aim of this article was to synopsize platelet-rich plasma (PRP) use in musculoskeletal
pathologies through evidence-based assessment of the preparation, classification …

Concern that misinformation from direct-to-consumer marketing of largely unproven
“biologic” treatments such as platelet-rich plasma and cell-based therapies may erode the …

Importance Most clinical guidelines do not recommend platelet-rich plasma (PRP) for knee
osteoarthritis (OA) because of lack of high-quality evidence on efficacy for symptoms and …

Aim: To evaluate the efficacy of autologous adipose-derived mesenchymal stem cell
(ADMSC) therapy on pain, function and disease modification in knee osteoarthritis. Methods …

Autologous and single‐donor allogenic platelet preparations are increasingly being used in
many areas of regenerative medicine. However, there are few properly controlled …

Purpose To establish consensus statements on platelet-rich plasma (PRP) for the treatment
of musculoskeletal pathologies. Methods A consensus process on the treatment of PRP …

Aims Hip arthroscopy (HA) has become the treatment of choice for femoroacetabular
impingement (FAI). However, less favourable outcomes following arthroscopic surgery are …

Objective Stem cell therapy is increasingly used for knee osteoarthritis (KOA). We aimed to
review the evidence of autologous mesenchymal stem cell therapy on pain, function and …

Bone marrow aspirate concentrate (BMAC) and adipose-derived stromal vascular fraction
(ADSVF) are the most marketed stem cell therapies to treat a variety of conditions in the …

Background: Platelet-rich plasma (PRP) and bone marrow concentrate (BMC) are
orthobiologic therapies with numerous growth factors and other bioactive molecules. Before …